Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1394-1399 , November 2009

Older Age But Not Donor Health Impairs Allogeneic Granulocyte Colony-Stimulating Factor (G-CSF) Peripheral Blood Stem Cell Mobilization

  • Elie Richa

      Affiliations

    • Biological Sciences Division, Department of Pathology, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • Corresponding Author InformationCorrespondence and reprint requests: Elie Richa, MD, Pathology, University of Chicago Medical Center, Chicago IL.
    • ,
  • Mona Papari

      Affiliations

    • Biological Sciences Division, Department of Pathology, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • ,
  • JoAnn Allen

      Affiliations

    • Biological Sciences Division, Department of Medicine, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • ,
  • Guadalupe Martinez

      Affiliations

    • Biological Sciences Division, Department of Medicine, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • ,
  • Amittha Wickrema

      Affiliations

    • Biological Sciences Division, Department of Medicine, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • ,
  • John Anastasi

      Affiliations

    • Biological Sciences Division, Department of Pathology, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • ,
  • Koen Van Besien

      Affiliations

    • Biological Sciences Division, Department of Medicine, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL
    • ,
  • Andrew Artz

      Affiliations

    • Biological Sciences Division, Department of Medicine, Section of Hematology-Oncology, University of Chicago Medical Center, Chicago IL

Received 6 May 2009 ,Accepted 3 July 2009.

References 

  1. Stroncek DF, Clay ME, Petzoldt ML, et al. Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion. 1996;36:601–610
  2. Bolan CD, Hartzman RJ, Perry EH, et al. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14:23–28
  3. Pulsipher MA, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113:3604–3611
  4. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant. 2005;36:575–590
  5. Karanes C, Nelson GO, Chitphakdithai P, et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14:8–15
  6. Nakamura R, Auayporn N, Smith DD, et al. Impact of graft cell dose on transplant outcomes following unrelated donor allogeneic peripheral blood stem cell transplantation: higher CD34+ cell doses are associated with decreased relapse rates. Biol Blood Marrow Transplant. 2008;14:449–457
  7. Bittencourt H, Rocha V, Chevret S, et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;99:2726–2733
  8. de la Rubia J, Arbona C, de Arriba F, et al. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion. 2002;42:4–9
  9. Lysak D, Koza V, Jindra P. Factors affecting PBSC mobilization and collection in healthy donors. Transfus Apher Sci. 2005;33:275–283
  10. Ings SJ, Balsa C, Leverett D, Mackinnon S, Linch DC, Watts MJ. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. Br J Haematol. 2006;134:517–525
  11. Anderlini P, Przepiorka D, Lauppe J, et al. Collection of peripheral blood stem cells from normal donors 60 years of age or older. Br J Haematol. 1997;97:485–487
  12. Suzuya H, Watanabe T, Nakagawa R, et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang. 2005;89:229–235
  13. Shimizu N, Asai T, Hashimoto S, et al. Mobilization factors of peripheral blood stem cells in healthy donors. Ther Apher. 2002;6:413–418
  14. Miflin G, Charley C, Stainer C, Anderson S, Hunter A, Russell N. Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. Br J Haematol. 1996;95:345–348
  15. Wang TF, Wen SH, Chen RL, et al. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transplant. 2008;14:1305–1311
  16. Vasu S, Leitman SF, Tisdale JF, et al. Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood. 2008;112:2092–2100
  17. de Lavallade H, Ladaique P, Lemarie C, et al. Older age does not influence allogeneic peripheral blood stem cell mobilization in a donor population of mostly white ethnic origin. Blood. 2009;113:1868–1869
  18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  19. Artz AS, Pollyea DA, Kocherginsky M, et al. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006;12:954–964
  20. Sacchi N, Costeas P, Hartwell L, et al. Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant. 2008;42:9–14
  21. Rhodes B, Anderlini P. Allogeneic peripheral blood stem cell collection as of 2008. Transfus Apher Sci. 2008;38:219–227
  22. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043–2051
  23. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576–4583
  24. Mehta J, Gordon LI, Tallman MS, et al. Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?. Bone Marrow Transplant. 2006;38:95–100
  25. Schetelig J, Bornhauser M, Schmid C, et al. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. J Clin Oncol. 2008;26:5183–5191
  26. Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–2919
  27. Rantanen T, Guralnik JM, Foley D, et al. Midlife hand grip strength as a predictor of old age disability. JAMA. 1999;281:558–560
  28. Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332:556–561
  29. Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20:494–502
  30. Xing Z, Ryan MA, Daria D, et al. Increased hematopoietic stem cell mobilization in aged mice. Blood. 2006;108:2190–2197
  31. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 2007;5:e201
  32. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature. 2007;447:725–729
  33. Platzbecker U, Bornhauser M, Zimmer K, et al. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells. Transfusion. 2005;45:11–15
  34. Anderlini P, Lauppe J, Przepiorka D, Seong D, Champlin R, Korbling M. Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections. Br J Haematol. 1997;96:415–417

 Financial disclosure: See Acknowledgments on page 1398.

PII: S1083-8791(09)00321-8

doi: 10.1016/j.bbmt.2009.07.005

Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1394-1399 , November 2009

Article Tools

* Image Usage & Resolution